Aims & Scope
Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments
in Pharmaceutical Biotechnology. Each issue of the journal includes timely
in-depth/mini reviews, original research articles and letters written by
leaders in the field, covering a range of current topics in scientific areas of
Pharmaceutical Biotechnology. Invited and unsolicited review articles are
welcome. The journal encourages contributions describing research at the
interface of drug discovery and pharmacological applications, involving in
vitro investigations and pre-clinical or clinical studies. Scientific areas
within the scope of the journal include pharmaceutical chemistry, biochemistry
and genetics, molecular and cellular biology, and polymer and materials
sciences as they relate to pharmaceutical science and biotechnology. In
addition, the journal also considers comprehensive studies and research
advances pertaining food chemistry with pharmaceutical implication. Areas of
interest include:
●
DNA/protein
engineering and processing
●
Synthetic
biotechnology
●
Omics
(genomics, proteomics, metabolomics and systems biology)
●
Therapeutic
biotechnology (gene therapy, peptide inhibitors, enzymes)
●
Drug
delivery and targeting
●
Nanobiotechnology
●
Molecular
pharmaceutics and molecular pharmacology
●
Analytical
biotechnology (biosensing, advanced technology for detection of bioanalytes)
●
Pharmacokinetics
and pharmacodynamics
●
Applied
Microbiology
●
Bioinformatics
(computational biopharmaceutics and modeling)
●
Environmental
biotechnology
●
Regenerative
medicine (stem cells, tissue engineering and biomaterials)
●
Translational
immunology (cell therapies, antibody engineering, xenotransplantation)
●
Industrial
bioprocesses for drug production and development
●
Biosafety
●
Biotech
ethics
Special Issues devoted to crucial topics, providing the
latest comprehensive information on cutting-edge areas of research and
technological advances, are welcome.
Current Pharmaceutical Biotechnology is an essential
journal for academic, clinical, government and pharmaceutical scientists who
wish to be kept informed and up-to-date with the latest and most important
developments.
